As HRSA considers whether to permit changes to the 340B Discount Drug Program, namely shifting to a rebate-based model – safety net hospitals and community health leaders are sounding the alarm. Under debate is whether drugs are sold at full price with rebates issued after purchase, rather than the traditional upfront discount many CHCs rely […]